- Home
- MYGN vs SGML Comparison
MYGN vs SGML Comparison
Compare MYGN & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- SGML
- Stock Information
- Founded
- MYGN 1991
- SGML 2011
- Country
- MYGN United States
- SGML Brazil
- Employees
- MYGN N/A
- SGML N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SGML Industrial Machinery/Components
- Sector
- MYGN Health Care
- SGML Industrials
- Exchange
- MYGN Nasdaq
- SGML Nasdaq
- Market Cap
- MYGN 744.7M
- SGML 879.0M
- IPO Year
- MYGN 1995
- SGML N/A
- Fundamental
- Price
- MYGN $4.13
- SGML $6.58
- Analyst Decision
- MYGN Hold
- SGML Strong Buy
- Analyst Count
- MYGN 16
- SGML 2
- Target Price
- MYGN $16.40
- SGML $18.00
- AVG Volume (30 Days)
- MYGN 3.4M
- SGML 1.0M
- Earning Date
- MYGN 05-06-2025
- SGML 05-14-2025
- Dividend Yield
- MYGN N/A
- SGML N/A
- EPS Growth
- MYGN N/A
- SGML N/A
- EPS
- MYGN N/A
- SGML N/A
- Revenue
- MYGN $831,300,000.00
- SGML $152,515,393.00
- Revenue This Year
- MYGN N/A
- SGML $43.73
- Revenue Next Year
- MYGN $7.21
- SGML $130.53
- P/E Ratio
- MYGN N/A
- SGML N/A
- Revenue Growth
- MYGN 7.38
- SGML 0.36
- 52 Week Low
- MYGN $3.98
- SGML $6.76
- 52 Week High
- MYGN $29.30
- SGML $19.20
- Technical
- Relative Strength Index (RSI)
- MYGN 25.47
- SGML 34.09
- Support Level
- MYGN $3.81
- SGML $7.22
- Resistance Level
- MYGN $4.31
- SGML $8.01
- Average True Range (ATR)
- MYGN 0.47
- SGML 0.48
- MACD
- MYGN -0.16
- SGML -0.00
- Stochastic Oscillator
- MYGN 8.00
- SGML 5.70
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.